Clinical Trial

ChatGPT-Supported Text Messaging Program for Smoking Cessation

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The current research proposal aims to explore how a purpose driven LLM ChatGPT chatbot, BeFreeBot, might enhance an evidence-based text messaging smoking cessation program, BeFree. The research will consist of a formative evaluation comparing quitting related outcomes among users of BeFree+Bot and BeFree.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-07-14; most recent amendment 2026-05-20.
Trial Details
NCT Number NCT07079306
Lead Sponsor George Washington University
Conditions Smoking Cessation
Enrollment 150 participants
Start Date 2026-10-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-22